Dr. Monther Abu-Remaileh's lab is interested in identifying novel pathways that enable cellular and organismal adaptation to metabolic stress and changes in environmental conditions. The lab also studies how these pathways go awry in human diseases such as cancer, neurodegeneration and metabolic syndrome, in order to engineer new therapeutic modalities.

Dr. Inma Cobos is a neuropathologist and neuroscientist with expertise in neurodegeneration. Her research program combines her background in diagnostic neuropathology, knowledge of developmental neuroscience, and state-of-the-art cellular and molecular technologies to advance the understanding of Alzheimer’s disease and related dementias. She is currently applying single-cell methods to human brain to dissect the contributions of distinct cell types to Alzheimer’s disease pathogenesis and investigate the mechanisms of tau-mediated neurodegeneration in human brain.

Dr. Ansuman Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-director of the Immunotherapy Program in the Stanford Cancer Institute. Ansu's research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics.

Dr. Jeremy Heit is a neurointerventional surgeon (neurointerventional radiologist) who specializes in treating stroke, brain aneurysms, brain arteriovenous malformations, brain and spinal dural arteriovenous fistulae, carotid artery stenosis, vertebral body compression fractures, and congenital vascular malformations. Dr. Heit treats all of these conditions using minimally-invasive, image-guided procedures and state-of-the-art technology.

Dr. Howitt is interested in elucidating cell of origin for gynecologic tumors, and mechanisms for detection of precursor lesions and early cancers, with the goal of preventive measures and targeted therapeutics.

Dr. Katherine Ferrara's laboratory has projects spanning all aspects of image-guided drug delivery. Major areas of interest include the fusion of images between ultrasound, PET, MRI and CT, the development of activatable drug delivery vehicles, and the development of molecularly-targeted drug delivery vehicles. Members of the Ferrara laboratory bring expertise in many areas including biomedical engineering, physics, electrical engineering, chemical engineering, mechanical engineering, computer science, material science, chemistry, and biology.

Dr. Prithvi Mruthyunjaya cares for patients with conditions related to cancer of the eye in both adults and children - either benign, pre-cancerous, or eye cancer. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body which spread to the eye, Coats' disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions) and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye related side effects of chemotherapy treatments.

Dr. Alice Bertaina's laboratory is focused on identifying innovative approaches of stem cell transplantation and molecular/genomic characterization of leukemia stem cells in myeloid pediatric hematologic malignancies.

Dr. Duchi's research interests span statistics, machine learning, computation, and optimization. Dr. Duchi's group seeks to understand how we can balance multiple criteria such as computation, communication, or privacy while maintaining statistical performance.

Dr. Crum's research focuses on how changes in subjective mindsets - the lenses through which information is perceived, organized, and interpreted - can alter objective reality through behavioral, psychological, and physiological mechanisms.